warnings about liver problems in patients taking Accolate (zafirlukast)
February 2003
There are now stronger warnings about liver problems in patients taking Accolate (zafirlukast).
Severe hepatitis is rare...but about 5% of patients can get elevated liver enzymes without any symptoms.
Counsel patients on Accolate to report signs of liver toxicity...fatigue, abdominal pain, jaundice, etc.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive